Eli Lilly launches new, cheaper form of weight loss drug
Eli Lilly launched a new form of its weight-loss drug Zepbound on Tuesday for about half the usual monthly list price, in an effort to reach millions of patients who…
Eli Lilly launched a new form of its weight-loss drug Zepbound on Tuesday for about half the usual monthly list price, in an effort to reach millions of patients who…
When BlackRock’s Tony DeSpirito looks for dividend-paying stocks for the firm’s flagship equity fund, he also looks for quality and value. That will come in handy in the “new era”…